Creative Biolabs-Immuno-oncology

Anti-CLEC12A (clone M2E9Q) SynExpress SV-mKa-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR1932)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CLEC12A (clone M2E9Q). We employs the pBR322 (SV40-mKate-IL-10-EcoRI) vector components and the SynExpress system of the Exons Base Editing/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CLEC12A
Clone
M2E9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
SV40
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Base Editing
Modification Domain
Exons
Carrier Type
pBR322
Transformation Accuracy
0.92
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving